PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. (Q46006542)

18 December 2017

title

PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. (English)

1 reference

18 December 2017

0 references

0 references

1 reference

Yuanyuan Ji

1

1 reference

18 December 2017

Juntian Liu

2

1 reference

18 December 2017

Zhidong Wang

3

1 reference

18 December 2017

Na Liu

4

1 reference

18 December 2017

Wei Gou

5

1 reference

18 December 2017

publication date

18 May 2009

1 reference

18 December 2017

published in

Laboratory Investigation

1 reference

18 December 2017

volume

89

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

887-902

1 reference

18 December 2017

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Angiotensin II and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Mechanisms linking angiotensin II and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Functionality of specific immunity in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Cooperation of Toll-like receptor signals in innate immune defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

PPARgamma and atherosclerosis: effects on cell growth and movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Antiinflammatory and antiarteriosclerotic effects of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

NF-kappaB signaling in lymphocytes: a new cast of characters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Toll-like receptors in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Matrix metalloproteinases in cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

TLR signaling: an emerging bridge from innate immunity to atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Peroxisome proliferator-activated receptors and cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Lipopolysaccharide signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.45

7 January 2021

10.1038/LABINVEST.2009.45

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1043506107

0 references

1 reference

18 December 2017